Filing Flows › Fresenius Medical Care AG (FMS) › Q2 2026
Fresenius Medical Care AG (FMS) Q2 2026 earnings results (second quarter 2026)
6-K filed Aug 3, 2026
Fresenius Medical Care AG (FMS) reported revenue of $4.9B for the second quarter 2026 (Q2 2026), +1% from a year earlier and -47% from the quarter before. Operating margin was 9.6%, net earnings $218M (4.5% of revenue).
Fresenius Medical Care AG, Q2 2026: revenue $4.9B (+1% year over year), operating margin 9.6%, net earnings $218M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.9B | -47% | +1% |
| Operating profit | $466M | +63% | +10% |
| Net earnings | $218M | +32% | -3% |
What changed
Revenue was €4.9B in Q2 2026, up 1% year over year and down 47% from the previous quarter.
Operating profit was €0.47B, a 9.6% margin (up 0.7 points year over year). Of the extra revenue versus a year earlier, 59% reached operating profit, above the 9% margin then. Total costs grew 1% against revenue growth of 1%. Net earnings were €0.22B, down 3% year over year. The effective tax rate was 0.0%.
Questions
What was Fresenius Medical Care AG's revenue in the second quarter 2026?
Fresenius Medical Care AG (FMS) reported revenue of $4.9B for the second quarter 2026 (Q2 2026), +1% from a year earlier and -47% from the quarter before.
Was Fresenius Medical Care AG profitable in the second quarter 2026?
Operating profit was $466M (9.6% of revenue) and net earnings $218M.